Irinotecan Bead: Phase IIb started

Biocompatibles began the Phase IIb portion of an open-label, U.S. Phase IIa/b trial to compare FOLFOX and Avastin bevacizumab with or without DEBIRI in 60 patients. Genentech Inc., a unit of Roche ...